ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 6969

$1.91M Total Retail Price of All Prescriptions

Rank: 35 out of 6969

615 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 615 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 25,235 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LOVAZA 1,318 1,171 1 77
AMLODIPINE BESYLATE 821 736 2 4
OMEPRAZOLE 761 677 3 6
LEVOTHYROXINE SODIUM 720 609 4 5
SIMVASTATIN 698 642 5 1
SINGULAIR 642 588 6 84
VOLTAREN 552 491 7 105
TRAMADOL HCL 543 463 8 27
CRESTOR 519 444 9 39
METFORMIN HCL 516 463 10 7
DIOVAN 515 476 11 26
ZOLPIDEM TARTRATE 512 471 12 16
CARVEDILOL 501 461 13 25
FUROSEMIDE 494 467 14 10
DIOVAN HCT 480 436 15 57
ATORVASTATIN CALCIUM 460 391 16 11
ATENOLOL 450 396 17 9
TAMSULOSIN HCL 391 377 18 23
FAMOTIDINE 390 349 19 37
MELOXICAM 386 383 20 36
GABAPENTIN 329 298 21 17
IBUPROFEN 322 238 22 29
LIDODERM 313 276 23 75
CILOSTAZOL 302 288 24 208
NEXIUM 301 271 25 52
METOPROLOL TARTRATE 291 260 26 13
DONEPEZIL HCL 258 258 27 32
MONTELUKAST SODIUM 256 238 28 151
PLAVIX 246 232 29 68
JANUVIA 235 191 30 41
GLIMEPIRIDE 226 202 31 44
MECLIZINE HCL 219 203 32 100
ATELVIA 216 187 33 111
ISOSORBIDE MONONITRATE ER 215 190 34 81
CLOPIDOGREL 208 185 35 48
SERTRALINE HCL 204 190 36 38
GLYBURIDE-METFORMIN HCL 200 141 R 37 92
POTASSIUM CHLORIDE 196 196 38 30
ALENDRONATE SODIUM 193 159 39 14
SYMBICORT 184 153 40 149
TRIAMCINOLONE ACETONIDE 175 142 41 55
FLUTICASONE PROPIONATE 173 155 42 24
SPIRIVA 172 158 43 66
ADVAIR DISKUS 165 153 44 45
LIPITOR 164 135 45 89
NATEGLINIDE 163 151 46 228
NITROGLYCERIN PATCH 158 144 47 256
BENICAR 156 149 48 107
BENAZEPRIL HCL 153 125 49 18
HYDROCODONE-ACETAMINOPHEN 146 120 S3 50 3
METOPROLOL SUCCINATE 145 126 51 22
ALLOPURINOL 142 117 52 35
LOSARTAN-HYDROCHLOROTHIAZIDE 142 123 52 53
PANTOPRAZOLE SODIUM 133 117 54 31
DICLOFENAC SODIUM 131 100 55 78
CREON 127 120 56 147
BENICAR HCT 124 87 57 176
ESCITALOPRAM OXALATE 122 115 58 93
PAROXETINE HCL 117 114 59 65
NASONEX 116 102 60 144
LISINOPRIL 112 112 61 2
NITROSTAT 112 94 61 210
RAMIPRIL 108 96 63 112
AZITHROMYCIN 108 80 63 42
COMBIVENT 104 99 65 170
FENOFIBRATE 103 74 66 63
NYSTATIN 103 94 66 215
AVODART 101 101 68 108
PATANOL 99 89 69 142
CELEBREX 98 66 70 67
PRANDIN 98 88 70 271
PROAIR HFA 97 96 72 33
MEGESTROL ACETATE 96 86 R 73 129
NAMENDA 96 96 73 51
DILTIAZEM 24HR CD 95 77 75 191
CLONIDINE HCL 95 93 75 59
CYMBALTA 94 82 77 72
SUCRALFATE 93 86 78 247
CEPHALEXIN 89 73 79 96
EFFIENT 88 66 80 272
SPIRONOLACTONE 88 75 80 102
JANUMET 86 63 82 138
PRAMIPEXOLE DIHYDROCHLORIDE 85 85 83 227
CARBIDOPA-LEVODOPA 83 83 84 119
LEVOFLOXACIN 82 70 85 109
WARFARIN SODIUM 79 79 86 20
DIGOXIN 79 78 86 71
KLOR-CON 8 76 76 88 104
NYSTATIN-TRIAMCINOLONE 76 72 88 278
INSULIN SYRINGE 75 74 90 60
THEOPHYLLINE ANHYDROUS 75 52 90 287
CIPROFLOXACIN HCL 75 67 90 64
HYDROXYZINE HCL 73 71 R 93 159
SYNTHROID 73 65 93 94
AMIODARONE HCL 72 72 95 184
ACIPHEX 72 58 95 181
LYRICA 72 72 95 137
ACTONEL 71 70 98 115
CLOTRIMAZOLE-BETAMETHASONE 71 55 98 182
SINGLE USE SWAB 70 58 100 306
KETOCONAZOLE 68 62 101 185
LANTUS 68 65 101 50
METHOTREXATE 67 47 103 385
LOSARTAN POTASSIUM 67 59 103 12
VESICARE 65 65 105 163
ENALAPRIL MALEATE 65 56 105 56
BUSPIRONE HCL 65 64 105 187
EXFORGE 63 49 108 190
TRICOR 63 54 108 143
RANEXA 63 49 108 357
ONGLYZA 63 46 108 164
AZOR 62 56 112 233
COREG CR 61 60 113 252
METHIMAZOLE 61 61 113 345
PRAVASTATIN SODIUM 60 60 115 19
PATADAY 58 56 116 213
DOXAZOSIN MESYLATE 58 58 116 74
AMLODIPINE BESYLATE-BENAZEPRIL 56 54 118 91
LEXAPRO 54 48 119 200
ZENPEP 54 41 119 283
NAPROXEN 53 48 121 62
OXYBUTYNIN CHLORIDE ER 53 42 121 165
RISPERIDONE 52 50 123 88
HYDRALAZINE HCL 52 52 123 106
DILTIAZEM 24HR ER 52 46 123 183
BONIVA 51 42 126 198
METOCLOPRAMIDE HCL 51 43 126 136
IBANDRONATE SODIUM 51 46 126 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.